MLTX STOCK LOSS: MoonLake Immunotherapeutics Faces Securities Fraud Class Action due to Drug Trial Results – Contact BFA Law if You Suffered Losses
MLTX STOCK LOSS: MoonLake Immunotherapeutics Faces Securities Fraud Class Action due to Drug Trial Results – Contact BFA Law if You Suffered Losses GlobeNewswire November 17, 2025 NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: […]